Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19087253 | PROSTHETIC DEVICE | March 2025 | October 2025 | Allow | 7 | 1 | 0 | Yes | No |
| 19023216 | COBALT-CHROMIUM ALLOY STENT AND DRUG ELUTING STENT | January 2025 | June 2025 | Allow | 5 | 1 | 0 | No | No |
| 18974434 | OMNI-VIEW UNIQUE TRACKING MARKER | December 2024 | October 2025 | Abandon | 11 | 2 | 0 | No | No |
| 18892020 | Devices And Methods for Bile Duct Surgery | September 2024 | August 2025 | Allow | 11 | 1 | 0 | No | No |
| 18804861 | Degradable biomedical magnesium alloy drug-eluting vascular stent and preparation method | August 2024 | May 2025 | Allow | 9 | 1 | 1 | Yes | No |
| 18587878 | METHOD OF PERFORMING A MINIMALLY INVASIVE BYPASS | February 2024 | November 2024 | Allow | 9 | 1 | 0 | Yes | No |
| 18577719 | LONG-ACTING ANTIBACTERIAL ANTI-STENOSIS FUNCTIONAL URETHRAL STENT AND PREPARATION METHOD THEREOF | January 2024 | March 2025 | Allow | 14 | 1 | 1 | Yes | No |
| 18510534 | PERCUTANEOUS MITRAL VALVE REPLACEMENT DEVICE | November 2023 | December 2025 | Allow | 25 | 2 | 1 | No | No |
| 18502935 | ADJUSTABLE ORTHOPEDIC CONNECTIONS | November 2023 | November 2025 | Allow | 24 | 3 | 0 | Yes | No |
| 18498402 | BIDIRECTIONAL STENT AND METHOD OF USE THEREOF | October 2023 | March 2026 | Allow | 29 | 1 | 0 | No | No |
| 18013510 | Covered Stent | May 2023 | April 2024 | Allow | 16 | 2 | 0 | Yes | No |
| 18130676 | Replacement Heart Valve with Reduced Suturing | April 2023 | October 2025 | Allow | 30 | 4 | 0 | Yes | No |
| 18194638 | MODULAR VALVE PROSTHESIS WITH ANCHOR STENT AND VALVE COMPONENT | April 2023 | February 2026 | Allow | 35 | 2 | 1 | No | No |
| 18177619 | METHOD FOR MAINTAINING PATENCY OF A PROSTATIC URETHRA LUMEN | March 2023 | June 2025 | Abandon | 28 | 2 | 0 | No | Yes |
| 18109937 | SYSTEMS AND METHODS FOR IMPLANTING A PROSTHETIC VALVE WITHIN A NATIVE HEART VALVE | February 2023 | November 2024 | Allow | 21 | 1 | 0 | No | No |
| 18156761 | Epicardial Anchor Devices And Methods | January 2023 | February 2025 | Allow | 25 | 1 | 0 | No | No |
| 18016042 | INTRAVASCULAR INDWELLING STENT | January 2023 | January 2026 | Allow | 36 | 1 | 0 | No | No |
| 18151196 | VENOUS VALVE PROSTHESIS | January 2023 | April 2025 | Abandon | 27 | 1 | 0 | No | No |
| 17937505 | PATCH TO TREAT CORNEAL PERFORATION | October 2022 | January 2026 | Abandon | 39 | 1 | 0 | No | No |
| 17901456 | Talar Implant System and Method | September 2022 | December 2024 | Allow | 28 | 1 | 0 | Yes | No |
| 17800741 | TRANSCATHETER SYSTEM AND METHOD FOR REDUCING TRICUSPID REGURGITATION | August 2022 | February 2026 | Allow | 42 | 2 | 0 | No | No |
| 17854795 | SCAFFOLDS WITH VIABLE TISSUE | June 2022 | April 2025 | Abandon | 33 | 1 | 1 | No | No |
| 17789060 | KNITTED STENT AND KNITTED STENT SYSTEM | June 2022 | January 2026 | Abandon | 43 | 1 | 0 | No | No |
| 17805597 | FIBER IMPLANT WITH INTERWOVEN DIFFERENT MATERIALS | June 2022 | October 2025 | Allow | 40 | 2 | 0 | Yes | No |
| 17779363 | DELIVERY GUIDE WIRE AND THERAPEUTIC DEVICE | May 2022 | November 2025 | Abandon | 42 | 1 | 0 | No | No |
| 17749591 | BIOGLUE APPLICATIONS IN THE AORTA | May 2022 | March 2026 | Abandon | 46 | 1 | 1 | No | No |
| 17778304 | Covered Stent | May 2022 | November 2023 | Allow | 18 | 2 | 0 | No | No |
| 17776350 | STENT, STENT PRECURSOR PRODUCTION DEVICE, AND STENT PRODUCTION METHOD | May 2022 | March 2026 | Abandon | 46 | 1 | 1 | No | No |
| 17662612 | MULTI-LUMEN STENT-GRAFT AND RELATED SURGICAL METHODS | May 2022 | August 2025 | Allow | 39 | 3 | 0 | Yes | No |
| 17739720 | VASCULAR PORT SYSTEM INCLUDING AN INTERCHANGEABLE STENT CARTRIDGE, AND METHOD THEREOF | May 2022 | February 2026 | Abandon | 45 | 1 | 1 | No | No |
| 17774977 | Stent Graft | May 2022 | August 2024 | Allow | 27 | 4 | 0 | Yes | No |
| 17773576 | TIPS Stent Graft and Kit | April 2022 | January 2025 | Allow | 32 | 4 | 0 | No | Yes |
| 17733751 | MECHANICALLY EXPANDABLE HEART VALVE WITH LEAFLET CLAMPS | April 2022 | March 2026 | Allow | 47 | 4 | 0 | No | No |
| 17727270 | SYSTEMS AND METHODS FOR ANCHORING AND RESTRAINING GASTROINTESTINAL PROSTHESES | April 2022 | December 2025 | Allow | 43 | 1 | 0 | No | No |
| 17768384 | BILIARY STENT HAVING WINDING AND FIXING MEMBER AROUND WHICH PULLING STRING IS WOUND | April 2022 | October 2025 | Allow | 42 | 1 | 0 | Yes | No |
| 17710106 | TAVR Load Force Reduction | March 2022 | November 2025 | Allow | 43 | 2 | 1 | Yes | No |
| 17703562 | STENT-GRAFT PROSTHESIS WITH PRESSURE RELIEF CHANNELS | March 2022 | March 2025 | Allow | 36 | 2 | 0 | No | No |
| 17761748 | ENDOPROSTHESIS AND METHOD OF MANUFACTURING AN ENDOPROSTHESIS | March 2022 | September 2025 | Abandon | 42 | 2 | 0 | No | No |
| 17590240 | NON-INVASIVELY AND SAFELY AND QUICKLY SURGICAL TECHNIQUE OF INSERTING T-SHAPED TUBE INTO STENOTIC TRACHEA | February 2022 | June 2025 | Allow | 41 | 1 | 0 | No | No |
| 17584157 | VALVE TRANSLOCATION DEVICE AND METHOD FOR THE TREATMENT OF FUNCTIONAL VALVE REGURGITATION | January 2022 | September 2025 | Abandon | 44 | 0 | 1 | No | No |
| 17418665 | Covered Stent and Preparation Method Therefor | January 2022 | February 2024 | Allow | 31 | 4 | 0 | Yes | No |
| 17574452 | ENDOVASCULAR STENT-GRAFT WITH AN EXTRAVASCULAR EXTENSION | January 2022 | December 2025 | Abandon | 47 | 4 | 0 | No | No |
| 17624675 | STENT GRAFT PROSTHESIS | January 2022 | February 2026 | Allow | 50 | 2 | 0 | Yes | No |
| 17615306 | LOAD COMPENSATION DEVICE, IN PARTICULAR OF GRAVITATIONAL LOADS, APPLICABLE TO EXOSKELETONS | November 2021 | July 2025 | Allow | 43 | 2 | 0 | Yes | No |
| 17530187 | ARTICULATED COMMISSURE VALVE STENTS AND METHODS | November 2021 | December 2024 | Allow | 37 | 2 | 0 | No | No |
| 17454043 | TWO-PART MITRAL VALVE AND IMPLANT METHOD | November 2021 | July 2024 | Allow | 32 | 1 | 0 | No | No |
| 17606956 | SYSTEMS AND METHODS FOR MAGNET-INDUCED ASSEMBLY TISSUE GRAFTS | October 2021 | January 2026 | Allow | 51 | 2 | 0 | Yes | No |
| 17500795 | PULSATILE VASCULAR STENT GRAFT | October 2021 | January 2026 | Abandon | 51 | 4 | 0 | Yes | No |
| 17497199 | MULTI-LUMEN STENT-GRAFT AND RELATED SURGICAL METHODS | October 2021 | March 2022 | Allow | 6 | 1 | 1 | No | No |
| 17494770 | TWO-PART BI-LEAFLET HEART VALVE PROSTHESES | October 2021 | June 2025 | Allow | 44 | 1 | 0 | No | No |
| 17480617 | STENT DELIVERY APPARATUS | September 2021 | August 2025 | Abandon | 47 | 2 | 0 | Yes | No |
| 17460429 | SMALL DIAMETER VASCULAR PROSTHESIS | August 2021 | January 2023 | Allow | 17 | 3 | 0 | Yes | No |
| 17399811 | METHOD OF USING AN ENDOVASCULAR STENT-GRAFT WITH AN EXTRAVASCULAR EXTENSION | August 2021 | August 2022 | Allow | 12 | 1 | 1 | No | No |
| 17395647 | INTRAOPERATIVE USES OF SETTABLE SURGICAL COMPOSITIONS | August 2021 | March 2024 | Allow | 31 | 1 | 1 | No | No |
| 17394303 | METHOD OF MANUFACTURING COVERED STENT AND COVERED STENT MANUFACTURED THEREBY | August 2021 | November 2025 | Allow | 51 | 4 | 1 | Yes | No |
| 17372940 | STENT AND METHOD OF MAKING SAME | July 2021 | October 2024 | Allow | 39 | 2 | 0 | No | No |
| 17305559 | DEVICE AND METHOD FOR MODIFYING THE SHAPE OF A BODY ORGAN | July 2021 | May 2022 | Allow | 10 | 2 | 0 | Yes | No |
| 17358567 | DEVICE, SYSTEM, AND METHOD FOR TRANSCATHETER TREATMENT OF VALVULAR REGURGITATION | June 2021 | April 2023 | Allow | 22 | 3 | 1 | Yes | No |
| 17354708 | FLEXIBLE HOLLOW LUMEN COMPOSITE | June 2021 | April 2025 | Abandon | 46 | 1 | 0 | No | No |
| 17327801 | Optimized Stent Jacket with Large Apertures | May 2021 | July 2024 | Abandon | 38 | 1 | 0 | No | No |
| 17318829 | PUNCTURABLE AND RESEALABLE GRAFT | May 2021 | August 2025 | Allow | 51 | 3 | 0 | Yes | Yes |
| 17241808 | WOVEN GRAFT HAVING A TAPER WITH A RE-ENGAGED WARP END | April 2021 | January 2024 | Allow | 32 | 2 | 1 | Yes | No |
| 17234999 | Biological Chord Repair System and Methods | April 2021 | April 2024 | Allow | 36 | 2 | 0 | No | No |
| 17226438 | PERCUTANEOUSLY DELIVERABLE HEART VALVE | April 2021 | November 2025 | Allow | 55 | 2 | 0 | Yes | No |
| 17214869 | Nasal Implants and Systems and Method of Use | March 2021 | September 2024 | Allow | 42 | 2 | 0 | Yes | No |
| 17214286 | MEDICAL DEVICE SUITABLE FOR LOCATION IN A BODY LUMEN | March 2021 | April 2024 | Abandon | 37 | 1 | 0 | No | No |
| 17181783 | INTRAVASCULAR IMPLANTS AND METHODS OF USING THE SAME | February 2021 | April 2024 | Abandon | 38 | 0 | 1 | No | No |
| 17178802 | PROSTHETIC VALVE WITH IMPROVED WASHOUT | February 2021 | January 2024 | Allow | 35 | 2 | 1 | No | No |
| 17174839 | METHODS AND USES OF BIOLOGICAL TISSUES FOR VARIOUS STENT AND OTHER MEDICAL APPLICATIONS | February 2021 | November 2024 | Abandon | 45 | 2 | 0 | No | No |
| 17146760 | SYSTEM AND METHOD FOR MEASURING BLOOD FLOW PARAMETERS IN A BLOOD VESSEL HAVING AN ENDOVASCULAR PROSTHESIS | January 2021 | February 2024 | Abandon | 37 | 1 | 0 | No | No |
| 17142887 | VASCULAR VALVE PROSTHESIS | January 2021 | December 2023 | Abandon | 35 | 1 | 0 | No | No |
| 17134542 | Stent assembly and methods for treatment via body lumens | December 2020 | May 2024 | Abandon | 41 | 2 | 0 | No | No |
| 17134318 | METHOD FOR HUMAN IMMORTALITY | December 2020 | December 2024 | Abandon | 48 | 1 | 0 | No | No |
| 17100345 | BIFURCATED SIDE-ACCESS INTRAVASCULAR STENT GRAFT | November 2020 | January 2022 | Abandon | 14 | 2 | 0 | Yes | No |
| 17073945 | GALVANIC REDOX MATERIAL AND IMPLANTABLE DEVICE AND METHODS THEREOF | October 2020 | December 2025 | Abandon | 60 | 3 | 1 | No | No |
| 17061347 | TRANSCATHETER DEVICE, SYSTEM AND METHOD FOR TREATING TYPE A AORTIC DISSECTION | October 2020 | December 2023 | Allow | 38 | 1 | 0 | Yes | No |
| 17015677 | IMPLANTABLE PROSTHETIC HEART VALVE | September 2020 | April 2021 | Allow | 7 | 1 | 0 | Yes | No |
| 17005746 | IMPLANTABLE VASCULAR DEVICE HAVING LONGITUDINAL STRUTS | August 2020 | March 2025 | Abandon | 55 | 3 | 0 | No | No |
| 16970460 | BRAIDED STRUCTURE, IN PARTICULAR STENT, AND METHOD FOR BRAIDING A BRAIDED STRUCTURE | August 2020 | July 2024 | Abandon | 47 | 4 | 1 | Yes | No |
| 16957941 | ABSORBABLE METAL STENT | June 2020 | July 2023 | Allow | 36 | 3 | 1 | No | No |
| 16955942 | SOFT TISSUE IMPLANT POCKET | June 2020 | February 2025 | Allow | 56 | 6 | 0 | Yes | No |
| 16888322 | VALVE TRANSLOCATION DEVICE AND METHOD FOR THE TREATMENT OF FUNCTIONAL VALVE REGURGITATION | May 2020 | November 2020 | Allow | 6 | 2 | 0 | Yes | No |
| 16879346 | DUAL VOLTAGE SOLAR PANEL | May 2020 | August 2024 | Allow | 51 | 2 | 0 | No | No |
| 16857914 | Heart Valve Assemblies | April 2020 | September 2023 | Abandon | 41 | 1 | 0 | No | No |
| 16843422 | STENT AND MEDICAL DEVICE COMPRISING SAME | April 2020 | March 2025 | Abandon | 60 | 4 | 0 | Yes | No |
| 16840403 | MODULAR VALVE PROSTHESIS WITH ANCHOR STENT AND VALVE COMPONENT | April 2020 | December 2022 | Allow | 32 | 0 | 0 | No | No |
| 16838625 | AIRWAY STENTS | April 2020 | March 2023 | Allow | 35 | 2 | 1 | Yes | No |
| 16649087 | TEXTILE INSERT FOR MEDICAL PURPOSES, AND METHOD FOR PRODUCING SAME | March 2020 | August 2023 | Abandon | 41 | 1 | 0 | No | No |
| 16648801 | IMPLANTABLE DEVICE | March 2020 | May 2025 | Allow | 60 | 5 | 0 | Yes | No |
| 16642730 | METAL ALLOY AND MEDICAL DEVICE CONTAINING SAME | February 2020 | April 2024 | Allow | 49 | 3 | 1 | Yes | No |
| 16790875 | Epicardial Anchor Devices And Methods | February 2020 | November 2022 | Allow | 33 | 2 | 0 | Yes | No |
| 16636891 | IMPLANTABLE DEVICE WITH ENHANCED DRUG DELIVERY AREA | February 2020 | January 2026 | Abandon | 60 | 6 | 1 | Yes | No |
| 16743049 | STENT INCLUDING ANTI-MIGRATION CAPABILITIES | January 2020 | February 2024 | Allow | 49 | 4 | 1 | Yes | No |
| 16630603 | Intravascular Stent, Especially for Coronary Vessels | January 2020 | July 2023 | Abandon | 42 | 2 | 0 | No | No |
| 16734881 | Replacement Mitral Valves | January 2020 | November 2022 | Allow | 34 | 2 | 0 | Yes | No |
| 16729382 | Mechanical Parts Including Pyrolytic Carbon Brace Members | December 2019 | September 2022 | Abandon | 32 | 1 | 0 | No | No |
| 16714712 | GEOMETRICALLY TUNABLE HYDROGEL-BASED CHEMICALLY-ELUTING SHUNT PROSTHESIS | December 2019 | September 2024 | Abandon | 58 | 3 | 1 | No | No |
| 16695522 | VALVE POSITIONING DEVICE | November 2019 | February 2026 | Abandon | 60 | 6 | 0 | Yes | Yes |
| 16695008 | ASSEMBLY OF HEART VALVES AND INTERMEDIATE ADAPTER STENT | November 2019 | May 2023 | Allow | 42 | 2 | 0 | Yes | No |
| 16612540 | INTRAVASCULAR RETRIEVABLE CELL DELIVERY SYSTEM | November 2019 | August 2024 | Allow | 57 | 3 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner PELLEGRINO, BRIAN E.
With a 22.2% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 25.5% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner PELLEGRINO, BRIAN E works in Art Unit 3799 and has examined 207 patent applications in our dataset. With an allowance rate of 72.5%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 39 months.
Examiner PELLEGRINO, BRIAN E's allowance rate of 72.5% places them in the 36% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.
On average, applications examined by PELLEGRINO, BRIAN E receive 3.07 office actions before reaching final disposition. This places the examiner in the 88% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by PELLEGRINO, BRIAN E is 39 months. This places the examiner in the 28% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +24.0% benefit to allowance rate for applications examined by PELLEGRINO, BRIAN E. This interview benefit is in the 70% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.
When applicants file an RCE with this examiner, 13.5% of applications are subsequently allowed. This success rate is in the 9% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 41.4% of cases where such amendments are filed. This entry rate is in the 63% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.
When applicants request a pre-appeal conference (PAC) with this examiner, 83.3% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 65% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.
This examiner withdraws rejections or reopens prosecution in 56.1% of appeals filed. This is in the 28% percentile among all examiners. Of these withdrawals, 56.5% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.
When applicants file petitions regarding this examiner's actions, 61.2% are granted (fully or in part). This grant rate is in the 66% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.
Examiner's Amendments: This examiner makes examiner's amendments in 3.9% of allowed cases (in the 82% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 4.0% of allowed cases (in the 77% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.